RecruitingPhase 3NCT05772104

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

A Multi-center, Randomized, Double-Blind Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder


Sponsor

Sichuan Jishengtang Pharmaceutical Co., Ltd.

Enrollment

495 participants

Start Date

Apr 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a traditional Chinese medicine capsule called Shugan Jieyu — commonly used for emotional distress — in people with generalized anxiety disorder (GAD). GAD is a condition where people experience persistent, difficult-to-control worry. Researchers want to see if this herbal treatment can reduce anxiety symptoms. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with generalized anxiety disorder for at least 6 months - Your anxiety symptoms are moderate to severe based on a standard rating scale (HAM-A score of 14 or higher) - Your symptoms match a traditional Chinese medicine pattern of liver Qi stagnation and spleen deficiency **You may NOT be eligible if...** - You have another psychiatric condition like bipolar disorder, schizophrenia, or severe depression - You have taken certain anxiety medications recently - You are pregnant or breastfeeding - You have serious physical health conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGShugan Jieyu Capsules

Oral, 4 Capsules, BID

DRUGShugan Jieyu Capsules Placebo

Drug: Shugan Jieyu Capsules Placebo, Oral,4 capsules,BID Drug: Placebo, Oral, 1 capsule, BID


Locations(1)

Beijing Anding Hospital Affiliated to Capital Medical University

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05772104


Related Trials